A CEO's View On Cancer, Virus-Based 'Cures,' And '60 Minutes' Vs. Reality

April 8, 2015 1:21 PM

14 0

Brad Thompson, CEO of Oncolytics Biotech Oncolytics Biotech, was thrilled to see CBS’ 60 Minutes bring attention to virus-based cancer treatments a couple weeks back, in a report focused on an engineered polio virus being developed at Duke University to treat glioblastoma, a deadly form of brain cancer. But Thompson also understands all too well the challenges of bringing these viruses to market, having guided his company through a sometimes brutal and public quest to develop a treatment that’s similar to the Duke approach.

Oncolytics Biotech was founded in 1998 on discoveries made at the University of Calgary about the cancer-killing prowess of reovirus, a bug that most people have been exposed to but that typically doesn’t cause infectious symptoms. The company went public on the Toronto Stock Exchange and Nasdaq a c...

Read more

To category page